nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—CYP1A2—Anagrelide—hematologic cancer	0.069	0.111	CbGbCtD
Levobupivacaine—CYP1A2—Carmustine—hematologic cancer	0.0363	0.0585	CbGbCtD
Levobupivacaine—CYP1A2—Methoxsalen—hematologic cancer	0.0308	0.0497	CbGbCtD
Levobupivacaine—CYP1A2—Bortezomib—hematologic cancer	0.0293	0.0473	CbGbCtD
Levobupivacaine—CYP1A2—Daunorubicin—hematologic cancer	0.028	0.0452	CbGbCtD
Levobupivacaine—CYP1A2—Alitretinoin—hematologic cancer	0.0275	0.0443	CbGbCtD
Levobupivacaine—CYP1A2—Thalidomide—hematologic cancer	0.0255	0.0412	CbGbCtD
Levobupivacaine—CYP3A4—Bexarotene—hematologic cancer	0.0251	0.0404	CbGbCtD
Levobupivacaine—CYP3A4—Lomustine—hematologic cancer	0.0233	0.0376	CbGbCtD
Levobupivacaine—CYP3A4—Busulfan—hematologic cancer	0.0233	0.0376	CbGbCtD
Levobupivacaine—CYP1A2—Dacarbazine—hematologic cancer	0.022	0.0354	CbGbCtD
Levobupivacaine—CYP1A2—Imatinib—hematologic cancer	0.0215	0.0346	CbGbCtD
Levobupivacaine—CYP3A4—Thiotepa—hematologic cancer	0.0208	0.0335	CbGbCtD
Levobupivacaine—CYP1A2—Dasatinib—hematologic cancer	0.0173	0.0278	CbGbCtD
Levobupivacaine—CYP3A4—Methoxsalen—hematologic cancer	0.0162	0.026	CbGbCtD
Levobupivacaine—CYP3A4—Bortezomib—hematologic cancer	0.0154	0.0248	CbGbCtD
Levobupivacaine—CYP3A4—Daunorubicin—hematologic cancer	0.0147	0.0237	CbGbCtD
Levobupivacaine—CYP3A4—Cytarabine—hematologic cancer	0.013	0.0209	CbGbCtD
Levobupivacaine—CYP3A4—Teniposide—hematologic cancer	0.0128	0.0206	CbGbCtD
Levobupivacaine—CYP3A4—Ifosfamide—hematologic cancer	0.0118	0.019	CbGbCtD
Levobupivacaine—CYP3A4—Imatinib—hematologic cancer	0.0113	0.0181	CbGbCtD
Levobupivacaine—CYP1A2—Etoposide—hematologic cancer	0.0107	0.0173	CbGbCtD
Levobupivacaine—CYP3A4—Ruxolitinib—hematologic cancer	0.0106	0.0171	CbGbCtD
Levobupivacaine—CYP3A4—Nilotinib—hematologic cancer	0.0102	0.0165	CbGbCtD
Levobupivacaine—CYP3A4—Vinorelbine—hematologic cancer	0.0101	0.0164	CbGbCtD
Levobupivacaine—CYP3A4—Triamcinolone—hematologic cancer	0.00928	0.015	CbGbCtD
Levobupivacaine—CYP3A4—Dasatinib—hematologic cancer	0.00904	0.0146	CbGbCtD
Levobupivacaine—CYP3A4—Mitoxantrone—hematologic cancer	0.00893	0.0144	CbGbCtD
Levobupivacaine—CYP3A4—Betamethasone—hematologic cancer	0.00796	0.0128	CbGbCtD
Levobupivacaine—CYP3A4—Prednisolone—hematologic cancer	0.00785	0.0127	CbGbCtD
Levobupivacaine—CYP3A4—Prednisone—hematologic cancer	0.00742	0.012	CbGbCtD
Levobupivacaine—CYP3A4—Irinotecan—hematologic cancer	0.00703	0.0113	CbGbCtD
Levobupivacaine—CYP3A4—Vinblastine—hematologic cancer	0.00625	0.0101	CbGbCtD
Levobupivacaine—CYP3A4—Vincristine—hematologic cancer	0.00615	0.00991	CbGbCtD
Levobupivacaine—CYP3A4—Etoposide—hematologic cancer	0.00563	0.00908	CbGbCtD
Levobupivacaine—CYP3A4—Dexamethasone—hematologic cancer	0.00463	0.00746	CbGbCtD
Levobupivacaine—CYP3A4—Doxorubicin—hematologic cancer	0.00384	0.00619	CbGbCtD
Levobupivacaine—SCN10A—Axon guidance—IL6R—hematologic cancer	5.58e-05	0.00153	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—MAP2K1—hematologic cancer	5.51e-05	0.00151	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—JAK1—hematologic cancer	5.51e-05	0.00151	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—MAP2K1—hematologic cancer	5.31e-05	0.00146	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTO1—hematologic cancer	5.04e-05	0.00138	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—JAK2—hematologic cancer	5.02e-05	0.00138	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GSTO1—hematologic cancer	4.97e-05	0.00136	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—hematologic cancer	4.9e-05	0.00134	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—JAK2—hematologic cancer	4.84e-05	0.00133	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—MAPK14—hematologic cancer	4.79e-05	0.00131	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—UGT1A1—hematologic cancer	4.74e-05	0.0013	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—CDK4—hematologic cancer	4.72e-05	0.00129	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—MET—hematologic cancer	4.72e-05	0.00129	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—hematologic cancer	4.7e-05	0.00129	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—UGT1A1—hematologic cancer	4.67e-05	0.00128	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	4.66e-05	0.00128	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase II conjugation—GSTP1—hematologic cancer	4.63e-05	0.00127	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—MAPK14—hematologic cancer	4.62e-05	0.00127	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—MET—hematologic cancer	4.55e-05	0.00125	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—CDK4—hematologic cancer	4.55e-05	0.00125	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—NOTCH1—hematologic cancer	4.54e-05	0.00125	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—NOTCH1—hematologic cancer	4.38e-05	0.0012	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—PTPN11—hematologic cancer	4.37e-05	0.0012	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	4.26e-05	0.00117	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase II conjugation—GSTM1—hematologic cancer	4.26e-05	0.00117	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—CREB1—hematologic cancer	4.23e-05	0.00116	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—PTPN11—hematologic cancer	4.21e-05	0.00115	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	4.2e-05	0.00115	CbGpPWpGaD
Levobupivacaine—CYP1A2—Tryptophan metabolism—MDM2—hematologic cancer	4.18e-05	0.00115	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—IL6R—hematologic cancer	4.13e-05	0.00113	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—CREBBP—hematologic cancer	4.12e-05	0.00113	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—MTR—hematologic cancer	4.11e-05	0.00113	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—CREB1—hematologic cancer	4.08e-05	0.00112	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—IL6R—hematologic cancer	3.98e-05	0.00109	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—CREBBP—hematologic cancer	3.97e-05	0.00109	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—MAP2K1—hematologic cancer	3.93e-05	0.00108	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTT1—hematologic cancer	3.91e-05	0.00107	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	3.89e-05	0.00107	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	3.84e-05	0.00105	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—SRC—hematologic cancer	3.82e-05	0.00105	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—hematologic cancer	3.82e-05	0.00105	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	3.82e-05	0.00105	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—MAP2K1—hematologic cancer	3.79e-05	0.00104	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	3.75e-05	0.00103	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—FGF2—hematologic cancer	3.74e-05	0.00103	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	3.74e-05	0.00102	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—VEGFA—hematologic cancer	3.72e-05	0.00102	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—SRC—hematologic cancer	3.69e-05	0.00101	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—NRAS—hematologic cancer	3.68e-05	0.00101	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	3.66e-05	0.001	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	3.63e-05	0.000996	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	3.61e-05	0.000989	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—FGF2—hematologic cancer	3.61e-05	0.000989	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—VEGFA—hematologic cancer	3.59e-05	0.000985	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—JAK2—hematologic cancer	3.59e-05	0.000983	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—NRAS—hematologic cancer	3.55e-05	0.000973	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hematologic cancer	3.52e-05	0.000966	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—MAPK3—hematologic cancer	3.52e-05	0.000966	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—JAK2—hematologic cancer	3.46e-05	0.000948	CbGpPWpGaD
Levobupivacaine—Insomnia—Dexamethasone—hematologic cancer	3.4e-05	9.92e-05	CcSEcCtD
Levobupivacaine—Insomnia—Betamethasone—hematologic cancer	3.4e-05	9.92e-05	CcSEcCtD
Levobupivacaine—Bradycardia—Doxorubicin—hematologic cancer	3.4e-05	9.9e-05	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—MAPK3—hematologic cancer	3.4e-05	0.000931	CbGpPWpGaD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.4e-05	9.89e-05	CcSEcCtD
Levobupivacaine—Paraesthesia—Betamethasone—hematologic cancer	3.38e-05	9.85e-05	CcSEcCtD
Levobupivacaine—Paraesthesia—Dexamethasone—hematologic cancer	3.38e-05	9.85e-05	CcSEcCtD
Levobupivacaine—Mental disorder—Methotrexate—hematologic cancer	3.38e-05	9.84e-05	CcSEcCtD
Levobupivacaine—Hypersensitivity—Etoposide—hematologic cancer	3.37e-05	9.82e-05	CcSEcCtD
Levobupivacaine—Tinnitus—Epirubicin—hematologic cancer	3.36e-05	9.8e-05	CcSEcCtD
Levobupivacaine—Erythema—Methotrexate—hematologic cancer	3.36e-05	9.78e-05	CcSEcCtD
Levobupivacaine—Malnutrition—Methotrexate—hematologic cancer	3.36e-05	9.78e-05	CcSEcCtD
Levobupivacaine—Headache—Gemcitabine—hematologic cancer	3.35e-05	9.77e-05	CcSEcCtD
Levobupivacaine—Nausea—Vincristine—hematologic cancer	3.35e-05	9.77e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	3.35e-05	0.000919	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—hematologic cancer	3.35e-05	0.000919	CbGpPWpGaD
Levobupivacaine—Flushing—Epirubicin—hematologic cancer	3.35e-05	9.76e-05	CcSEcCtD
Levobupivacaine—Cardiac disorder—Epirubicin—hematologic cancer	3.35e-05	9.76e-05	CcSEcCtD
Levobupivacaine—Hypersensitivity—Prednisolone—hematologic cancer	3.32e-05	9.68e-05	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Doxorubicin—hematologic cancer	3.32e-05	9.68e-05	CcSEcCtD
Levobupivacaine—Dyspepsia—Betamethasone—hematologic cancer	3.31e-05	9.65e-05	CcSEcCtD
Levobupivacaine—Dyspepsia—Dexamethasone—hematologic cancer	3.31e-05	9.65e-05	CcSEcCtD
Levobupivacaine—Urticaria—Triamcinolone—hematologic cancer	3.3e-05	9.6e-05	CcSEcCtD
Levobupivacaine—Oedema peripheral—Doxorubicin—hematologic cancer	3.29e-05	9.58e-05	CcSEcCtD
Levobupivacaine—Asthenia—Etoposide—hematologic cancer	3.28e-05	9.56e-05	CcSEcCtD
Levobupivacaine—Body temperature increased—Triamcinolone—hematologic cancer	3.28e-05	9.55e-05	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Prednisone—hematologic cancer	3.28e-05	9.55e-05	CcSEcCtD
Levobupivacaine—Oedema—Prednisone—hematologic cancer	3.28e-05	9.55e-05	CcSEcCtD
Levobupivacaine—Decreased appetite—Betamethasone—hematologic cancer	3.27e-05	9.53e-05	CcSEcCtD
Levobupivacaine—Decreased appetite—Dexamethasone—hematologic cancer	3.27e-05	9.53e-05	CcSEcCtD
Levobupivacaine—Nausea—Mitoxantrone—hematologic cancer	3.27e-05	9.51e-05	CcSEcCtD
Levobupivacaine—Nausea—Irinotecan—hematologic cancer	3.27e-05	9.51e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	3.26e-05	0.000894	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—hematologic cancer	3.26e-05	0.000894	CbGpPWpGaD
Levobupivacaine—Infection—Prednisone—hematologic cancer	3.26e-05	9.49e-05	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.25e-05	9.47e-05	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.25e-05	9.47e-05	CcSEcCtD
Levobupivacaine—Back pain—Methotrexate—hematologic cancer	3.25e-05	9.46e-05	CcSEcCtD
Levobupivacaine—Chills—Epirubicin—hematologic cancer	3.24e-05	9.43e-05	CcSEcCtD
Levobupivacaine—Pruritus—Etoposide—hematologic cancer	3.24e-05	9.43e-05	CcSEcCtD
Levobupivacaine—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	3.23e-05	0.000885	CbGpPWpGaD
Levobupivacaine—Shock—Prednisone—hematologic cancer	3.22e-05	9.39e-05	CcSEcCtD
Levobupivacaine—Arrhythmia—Epirubicin—hematologic cancer	3.22e-05	9.39e-05	CcSEcCtD
Levobupivacaine—Pain—Dexamethasone—hematologic cancer	3.22e-05	9.38e-05	CcSEcCtD
Levobupivacaine—Pain—Betamethasone—hematologic cancer	3.22e-05	9.38e-05	CcSEcCtD
Levobupivacaine—Nervous system disorder—Prednisone—hematologic cancer	3.21e-05	9.36e-05	CcSEcCtD
Levobupivacaine—Tachycardia—Prednisone—hematologic cancer	3.2e-05	9.32e-05	CcSEcCtD
Levobupivacaine—Skin disorder—Prednisone—hematologic cancer	3.18e-05	9.27e-05	CcSEcCtD
Levobupivacaine—Nausea—Gemcitabine—hematologic cancer	3.18e-05	9.27e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—hematologic cancer	3.18e-05	0.00087	CbGpPWpGaD
Levobupivacaine—Vomiting—Cisplatin—hematologic cancer	3.17e-05	9.25e-05	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—MTR—hematologic cancer	3.17e-05	0.000869	CbGpPWpGaD
Levobupivacaine—Hyperhidrosis—Prednisone—hematologic cancer	3.17e-05	9.23e-05	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—KRAS—hematologic cancer	3.17e-05	0.000868	CbGpPWpGaD
Levobupivacaine—Vision blurred—Methotrexate—hematologic cancer	3.16e-05	9.21e-05	CcSEcCtD
Levobupivacaine—Mental disorder—Epirubicin—hematologic cancer	3.16e-05	9.21e-05	CcSEcCtD
Levobupivacaine—Malnutrition—Epirubicin—hematologic cancer	3.14e-05	9.15e-05	CcSEcCtD
Levobupivacaine—Erythema—Epirubicin—hematologic cancer	3.14e-05	9.15e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	3.14e-05	0.00086	CbGpPWpGaD
Levobupivacaine—Diarrhoea—Etoposide—hematologic cancer	3.13e-05	9.12e-05	CcSEcCtD
Levobupivacaine—Tinnitus—Doxorubicin—hematologic cancer	3.11e-05	9.07e-05	CcSEcCtD
Levobupivacaine—Anaemia—Methotrexate—hematologic cancer	3.1e-05	9.04e-05	CcSEcCtD
Levobupivacaine—Feeling abnormal—Betamethasone—hematologic cancer	3.1e-05	9.03e-05	CcSEcCtD
Levobupivacaine—Feeling abnormal—Dexamethasone—hematologic cancer	3.1e-05	9.03e-05	CcSEcCtD
Levobupivacaine—Flushing—Doxorubicin—hematologic cancer	3.1e-05	9.03e-05	CcSEcCtD
Levobupivacaine—Cardiac disorder—Doxorubicin—hematologic cancer	3.1e-05	9.03e-05	CcSEcCtD
Levobupivacaine—Flatulence—Epirubicin—hematologic cancer	3.09e-05	9.02e-05	CcSEcCtD
Levobupivacaine—Tension—Epirubicin—hematologic cancer	3.08e-05	8.98e-05	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.08e-05	8.97e-05	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.08e-05	8.97e-05	CcSEcCtD
Levobupivacaine—Hypersensitivity—Triamcinolone—hematologic cancer	3.06e-05	8.9e-05	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—KRAS—hematologic cancer	3.05e-05	0.000837	CbGpPWpGaD
Levobupivacaine—Nervousness—Epirubicin—hematologic cancer	3.05e-05	8.89e-05	CcSEcCtD
Levobupivacaine—Back pain—Epirubicin—hematologic cancer	3.04e-05	8.85e-05	CcSEcCtD
Levobupivacaine—Dizziness—Etoposide—hematologic cancer	3.02e-05	8.81e-05	CcSEcCtD
Levobupivacaine—Muscle spasms—Epirubicin—hematologic cancer	3.02e-05	8.8e-05	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	3.02e-05	0.000827	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	3e-05	0.000823	CbGpPWpGaD
Levobupivacaine—Chills—Doxorubicin—hematologic cancer	3e-05	8.73e-05	CcSEcCtD
Levobupivacaine—Urticaria—Dexamethasone—hematologic cancer	2.99e-05	8.71e-05	CcSEcCtD
Levobupivacaine—Urticaria—Betamethasone—hematologic cancer	2.99e-05	8.71e-05	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.99e-05	8.7e-05	CcSEcCtD
Levobupivacaine—Dizziness—Prednisolone—hematologic cancer	2.98e-05	8.69e-05	CcSEcCtD
Levobupivacaine—Arrhythmia—Doxorubicin—hematologic cancer	2.98e-05	8.69e-05	CcSEcCtD
Levobupivacaine—Asthenia—Triamcinolone—hematologic cancer	2.98e-05	8.67e-05	CcSEcCtD
Levobupivacaine—Body temperature increased—Betamethasone—hematologic cancer	2.98e-05	8.67e-05	CcSEcCtD
Levobupivacaine—Abdominal pain—Betamethasone—hematologic cancer	2.98e-05	8.67e-05	CcSEcCtD
Levobupivacaine—Abdominal pain—Dexamethasone—hematologic cancer	2.98e-05	8.67e-05	CcSEcCtD
Levobupivacaine—Body temperature increased—Dexamethasone—hematologic cancer	2.98e-05	8.67e-05	CcSEcCtD
Levobupivacaine—Nausea—Cisplatin—hematologic cancer	2.96e-05	8.64e-05	CcSEcCtD
Levobupivacaine—Insomnia—Prednisone—hematologic cancer	2.96e-05	8.64e-05	CcSEcCtD
Levobupivacaine—Vision blurred—Epirubicin—hematologic cancer	2.96e-05	8.62e-05	CcSEcCtD
Levobupivacaine—Paraesthesia—Prednisone—hematologic cancer	2.94e-05	8.57e-05	CcSEcCtD
Levobupivacaine—Pruritus—Triamcinolone—hematologic cancer	2.93e-05	8.55e-05	CcSEcCtD
Levobupivacaine—Cough—Methotrexate—hematologic cancer	2.93e-05	8.53e-05	CcSEcCtD
Levobupivacaine—Mental disorder—Doxorubicin—hematologic cancer	2.92e-05	8.52e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	2.92e-05	0.000801	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	2.91e-05	0.000799	CbGpPWpGaD
Levobupivacaine—Convulsion—Methotrexate—hematologic cancer	2.91e-05	8.47e-05	CcSEcCtD
Levobupivacaine—Vomiting—Etoposide—hematologic cancer	2.91e-05	8.47e-05	CcSEcCtD
Levobupivacaine—Erythema—Doxorubicin—hematologic cancer	2.91e-05	8.47e-05	CcSEcCtD
Levobupivacaine—Malnutrition—Doxorubicin—hematologic cancer	2.91e-05	8.47e-05	CcSEcCtD
Levobupivacaine—Anaemia—Epirubicin—hematologic cancer	2.9e-05	8.46e-05	CcSEcCtD
Levobupivacaine—Agitation—Epirubicin—hematologic cancer	2.89e-05	8.41e-05	CcSEcCtD
Levobupivacaine—Dyspepsia—Prednisone—hematologic cancer	2.89e-05	8.4e-05	CcSEcCtD
Levobupivacaine—Headache—Etoposide—hematologic cancer	2.86e-05	8.35e-05	CcSEcCtD
Levobupivacaine—Flatulence—Doxorubicin—hematologic cancer	2.86e-05	8.34e-05	CcSEcCtD
Levobupivacaine—Arthralgia—Methotrexate—hematologic cancer	2.86e-05	8.32e-05	CcSEcCtD
Levobupivacaine—Tension—Doxorubicin—hematologic cancer	2.85e-05	8.31e-05	CcSEcCtD
Levobupivacaine—Decreased appetite—Prednisone—hematologic cancer	2.85e-05	8.3e-05	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.84e-05	8.27e-05	CcSEcCtD
Levobupivacaine—Headache—Prednisolone—hematologic cancer	2.83e-05	8.23e-05	CcSEcCtD
Levobupivacaine—Nervousness—Doxorubicin—hematologic cancer	2.82e-05	8.22e-05	CcSEcCtD
Levobupivacaine—Syncope—Epirubicin—hematologic cancer	2.82e-05	8.21e-05	CcSEcCtD
Levobupivacaine—Back pain—Doxorubicin—hematologic cancer	2.81e-05	8.19e-05	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—EP300—hematologic cancer	2.81e-05	0.000769	CbGpPWpGaD
Levobupivacaine—Constipation—Prednisone—hematologic cancer	2.8e-05	8.17e-05	CcSEcCtD
Levobupivacaine—Muscle spasms—Doxorubicin—hematologic cancer	2.79e-05	8.14e-05	CcSEcCtD
Levobupivacaine—Palpitations—Epirubicin—hematologic cancer	2.78e-05	8.09e-05	CcSEcCtD
Levobupivacaine—Confusional state—Methotrexate—hematologic cancer	2.76e-05	8.05e-05	CcSEcCtD
Levobupivacaine—Loss of consciousness—Epirubicin—hematologic cancer	2.76e-05	8.04e-05	CcSEcCtD
Levobupivacaine—Dizziness—Triamcinolone—hematologic cancer	2.74e-05	7.99e-05	CcSEcCtD
Levobupivacaine—Cough—Epirubicin—hematologic cancer	2.74e-05	7.98e-05	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Methotrexate—hematologic cancer	2.74e-05	7.98e-05	CcSEcCtD
Levobupivacaine—Vision blurred—Doxorubicin—hematologic cancer	2.74e-05	7.98e-05	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—SRC—hematologic cancer	2.73e-05	0.000748	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	2.72e-05	0.000746	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	2.72e-05	0.000746	CbGpPWpGaD
Levobupivacaine—Convulsion—Epirubicin—hematologic cancer	2.72e-05	7.93e-05	CcSEcCtD
Levobupivacaine—Infection—Methotrexate—hematologic cancer	2.72e-05	7.93e-05	CcSEcCtD
Levobupivacaine—Nausea—Etoposide—hematologic cancer	2.72e-05	7.91e-05	CcSEcCtD
Levobupivacaine—Hypertension—Epirubicin—hematologic cancer	2.71e-05	7.9e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—GSTP1—hematologic cancer	2.71e-05	0.000743	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—EP300—hematologic cancer	2.71e-05	0.000742	CbGpPWpGaD
Levobupivacaine—Feeling abnormal—Prednisone—hematologic cancer	2.7e-05	7.87e-05	CcSEcCtD
Levobupivacaine—Asthenia—Dexamethasone—hematologic cancer	2.7e-05	7.87e-05	CcSEcCtD
Levobupivacaine—Asthenia—Betamethasone—hematologic cancer	2.7e-05	7.87e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	2.7e-05	0.00074	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—HRAS—hematologic cancer	2.69e-05	0.000738	CbGpPWpGaD
Levobupivacaine—Nervous system disorder—Methotrexate—hematologic cancer	2.69e-05	7.83e-05	CcSEcCtD
Levobupivacaine—Anaemia—Doxorubicin—hematologic cancer	2.69e-05	7.83e-05	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Prednisone—hematologic cancer	2.68e-05	7.81e-05	CcSEcCtD
Levobupivacaine—Nausea—Prednisolone—hematologic cancer	2.68e-05	7.8e-05	CcSEcCtD
Levobupivacaine—Arthralgia—Epirubicin—hematologic cancer	2.67e-05	7.79e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GSTP1—hematologic cancer	2.67e-05	0.000732	CbGpPWpGaD
Levobupivacaine—Agitation—Doxorubicin—hematologic cancer	2.67e-05	7.78e-05	CcSEcCtD
Levobupivacaine—Anxiety—Epirubicin—hematologic cancer	2.66e-05	7.76e-05	CcSEcCtD
Levobupivacaine—Pruritus—Betamethasone—hematologic cancer	2.66e-05	7.76e-05	CcSEcCtD
Levobupivacaine—Pruritus—Dexamethasone—hematologic cancer	2.66e-05	7.76e-05	CcSEcCtD
Levobupivacaine—Skin disorder—Methotrexate—hematologic cancer	2.66e-05	7.75e-05	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—VEGFA—hematologic cancer	2.66e-05	0.000729	CbGpPWpGaD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.66e-05	7.74e-05	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Methotrexate—hematologic cancer	2.65e-05	7.71e-05	CcSEcCtD
Levobupivacaine—Vomiting—Triamcinolone—hematologic cancer	2.64e-05	7.68e-05	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—STAT3—hematologic cancer	2.63e-05	0.000721	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—SRC—hematologic cancer	2.63e-05	0.000721	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—NRAS—hematologic cancer	2.63e-05	0.00072	CbGpPWpGaD
Levobupivacaine—Syncope—Doxorubicin—hematologic cancer	2.61e-05	7.59e-05	CcSEcCtD
Levobupivacaine—Urticaria—Prednisone—hematologic cancer	2.6e-05	7.59e-05	CcSEcCtD
Levobupivacaine—Headache—Triamcinolone—hematologic cancer	2.6e-05	7.57e-05	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—HRAS—hematologic cancer	2.6e-05	0.000711	CbGpPWpGaD
Levobupivacaine—Body temperature increased—Prednisone—hematologic cancer	2.59e-05	7.55e-05	CcSEcCtD
Levobupivacaine—Abdominal pain—Prednisone—hematologic cancer	2.59e-05	7.55e-05	CcSEcCtD
Levobupivacaine—Confusional state—Epirubicin—hematologic cancer	2.58e-05	7.53e-05	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—IL6—hematologic cancer	2.58e-05	0.000706	CbGpPWpGaD
Levobupivacaine—Diarrhoea—Dexamethasone—hematologic cancer	2.57e-05	7.5e-05	CcSEcCtD
Levobupivacaine—Diarrhoea—Betamethasone—hematologic cancer	2.57e-05	7.5e-05	CcSEcCtD
Levobupivacaine—Palpitations—Doxorubicin—hematologic cancer	2.57e-05	7.48e-05	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Epirubicin—hematologic cancer	2.56e-05	7.47e-05	CcSEcCtD
Levobupivacaine—Oedema—Epirubicin—hematologic cancer	2.56e-05	7.47e-05	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—VEGFA—hematologic cancer	2.56e-05	0.000703	CbGpPWpGaD
Levobupivacaine—Hypotension—Methotrexate—hematologic cancer	2.56e-05	7.46e-05	CcSEcCtD
Levobupivacaine—Loss of consciousness—Doxorubicin—hematologic cancer	2.55e-05	7.44e-05	CcSEcCtD
Levobupivacaine—Infection—Epirubicin—hematologic cancer	2.55e-05	7.42e-05	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—STAT3—hematologic cancer	2.54e-05	0.000696	CbGpPWpGaD
Levobupivacaine—Cough—Doxorubicin—hematologic cancer	2.54e-05	7.39e-05	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—NRAS—hematologic cancer	2.53e-05	0.000694	CbGpPWpGaD
Levobupivacaine—Shock—Epirubicin—hematologic cancer	2.52e-05	7.35e-05	CcSEcCtD
Levobupivacaine—Convulsion—Doxorubicin—hematologic cancer	2.52e-05	7.34e-05	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—MAPK3—hematologic cancer	2.51e-05	0.000689	CbGpPWpGaD
Levobupivacaine—Nervous system disorder—Epirubicin—hematologic cancer	2.51e-05	7.32e-05	CcSEcCtD
Levobupivacaine—Hypertension—Doxorubicin—hematologic cancer	2.51e-05	7.31e-05	CcSEcCtD
Levobupivacaine—Tachycardia—Epirubicin—hematologic cancer	2.5e-05	7.29e-05	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.5e-05	7.27e-05	CcSEcCtD
Levobupivacaine—Skin disorder—Epirubicin—hematologic cancer	2.49e-05	7.25e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—GSTM1—hematologic cancer	2.49e-05	0.000682	CbGpPWpGaD
Levobupivacaine—Dizziness—Dexamethasone—hematologic cancer	2.49e-05	7.25e-05	CcSEcCtD
Levobupivacaine—Dizziness—Betamethasone—hematologic cancer	2.49e-05	7.25e-05	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—IL6—hematologic cancer	2.48e-05	0.000681	CbGpPWpGaD
Levobupivacaine—Hyperhidrosis—Epirubicin—hematologic cancer	2.48e-05	7.22e-05	CcSEcCtD
Levobupivacaine—Insomnia—Methotrexate—hematologic cancer	2.48e-05	7.22e-05	CcSEcCtD
Levobupivacaine—Arthralgia—Doxorubicin—hematologic cancer	2.47e-05	7.21e-05	CcSEcCtD
Levobupivacaine—Anxiety—Doxorubicin—hematologic cancer	2.47e-05	7.18e-05	CcSEcCtD
Levobupivacaine—Nausea—Triamcinolone—hematologic cancer	2.46e-05	7.18e-05	CcSEcCtD
Levobupivacaine—Paraesthesia—Methotrexate—hematologic cancer	2.46e-05	7.17e-05	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.46e-05	7.16e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GSTM1—hematologic cancer	2.46e-05	0.000673	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	2.45e-05	0.000671	CbGpPWpGaD
Levobupivacaine—Dyspnoea—Methotrexate—hematologic cancer	2.44e-05	7.11e-05	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—TGFB1—hematologic cancer	2.44e-05	0.000669	CbGpPWpGaD
Levobupivacaine—Somnolence—Methotrexate—hematologic cancer	2.44e-05	7.09e-05	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—MAPK3—hematologic cancer	2.42e-05	0.000665	CbGpPWpGaD
Levobupivacaine—Hypersensitivity—Prednisone—hematologic cancer	2.41e-05	7.03e-05	CcSEcCtD
Levobupivacaine—Dyspepsia—Methotrexate—hematologic cancer	2.41e-05	7.02e-05	CcSEcCtD
Levobupivacaine—Hypotension—Epirubicin—hematologic cancer	2.4e-05	6.98e-05	CcSEcCtD
Levobupivacaine—Vomiting—Dexamethasone—hematologic cancer	2.39e-05	6.97e-05	CcSEcCtD
Levobupivacaine—Vomiting—Betamethasone—hematologic cancer	2.39e-05	6.97e-05	CcSEcCtD
Levobupivacaine—Confusional state—Doxorubicin—hematologic cancer	2.39e-05	6.97e-05	CcSEcCtD
Levobupivacaine—Decreased appetite—Methotrexate—hematologic cancer	2.38e-05	6.94e-05	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Doxorubicin—hematologic cancer	2.37e-05	6.91e-05	CcSEcCtD
Levobupivacaine—Oedema—Doxorubicin—hematologic cancer	2.37e-05	6.91e-05	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.36e-05	6.89e-05	CcSEcCtD
Levobupivacaine—Headache—Dexamethasone—hematologic cancer	2.36e-05	6.87e-05	CcSEcCtD
Levobupivacaine—Headache—Betamethasone—hematologic cancer	2.36e-05	6.87e-05	CcSEcCtD
Levobupivacaine—Infection—Doxorubicin—hematologic cancer	2.36e-05	6.86e-05	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—TGFB1—hematologic cancer	2.35e-05	0.000645	CbGpPWpGaD
Levobupivacaine—Asthenia—Prednisone—hematologic cancer	2.35e-05	6.85e-05	CcSEcCtD
Levobupivacaine—Pain—Methotrexate—hematologic cancer	2.34e-05	6.82e-05	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.34e-05	6.8e-05	CcSEcCtD
Levobupivacaine—Shock—Doxorubicin—hematologic cancer	2.33e-05	6.8e-05	CcSEcCtD
Levobupivacaine—Nervous system disorder—Doxorubicin—hematologic cancer	2.33e-05	6.78e-05	CcSEcCtD
Levobupivacaine—Pruritus—Prednisone—hematologic cancer	2.32e-05	6.76e-05	CcSEcCtD
Levobupivacaine—Insomnia—Epirubicin—hematologic cancer	2.32e-05	6.75e-05	CcSEcCtD
Levobupivacaine—Tachycardia—Doxorubicin—hematologic cancer	2.31e-05	6.74e-05	CcSEcCtD
Levobupivacaine—Skin disorder—Doxorubicin—hematologic cancer	2.3e-05	6.71e-05	CcSEcCtD
Levobupivacaine—Paraesthesia—Epirubicin—hematologic cancer	2.3e-05	6.71e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	2.29e-05	0.000629	CbGpPWpGaD
Levobupivacaine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.29e-05	6.68e-05	CcSEcCtD
Levobupivacaine—Dyspnoea—Epirubicin—hematologic cancer	2.29e-05	6.66e-05	CcSEcCtD
Levobupivacaine—Somnolence—Epirubicin—hematologic cancer	2.28e-05	6.64e-05	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—TNF—hematologic cancer	2.28e-05	0.000624	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—KRAS—hematologic cancer	2.26e-05	0.000619	CbGpPWpGaD
Levobupivacaine—Feeling abnormal—Methotrexate—hematologic cancer	2.26e-05	6.58e-05	CcSEcCtD
Levobupivacaine—Dyspepsia—Epirubicin—hematologic cancer	2.26e-05	6.57e-05	CcSEcCtD
Levobupivacaine—Diarrhoea—Prednisone—hematologic cancer	2.24e-05	6.53e-05	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.24e-05	6.53e-05	CcSEcCtD
Levobupivacaine—Nausea—Dexamethasone—hematologic cancer	2.24e-05	6.51e-05	CcSEcCtD
Levobupivacaine—Nausea—Betamethasone—hematologic cancer	2.24e-05	6.51e-05	CcSEcCtD
Levobupivacaine—Decreased appetite—Epirubicin—hematologic cancer	2.23e-05	6.49e-05	CcSEcCtD
Levobupivacaine—Hypotension—Doxorubicin—hematologic cancer	2.22e-05	6.46e-05	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.21e-05	6.45e-05	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—TNF—hematologic cancer	2.2e-05	0.000602	CbGpPWpGaD
Levobupivacaine—Constipation—Epirubicin—hematologic cancer	2.19e-05	6.39e-05	CcSEcCtD
Levobupivacaine—Pain—Epirubicin—hematologic cancer	2.19e-05	6.39e-05	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—KRAS—hematologic cancer	2.18e-05	0.000597	CbGpPWpGaD
Levobupivacaine—Urticaria—Methotrexate—hematologic cancer	2.18e-05	6.34e-05	CcSEcCtD
Levobupivacaine—Dizziness—Prednisone—hematologic cancer	2.17e-05	6.31e-05	CcSEcCtD
Levobupivacaine—Body temperature increased—Methotrexate—hematologic cancer	2.17e-05	6.31e-05	CcSEcCtD
Levobupivacaine—Abdominal pain—Methotrexate—hematologic cancer	2.17e-05	6.31e-05	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.16e-05	6.3e-05	CcSEcCtD
Levobupivacaine—Insomnia—Doxorubicin—hematologic cancer	2.15e-05	6.25e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	2.14e-05	0.000587	CbGpPWpGaD
Levobupivacaine—Paraesthesia—Doxorubicin—hematologic cancer	2.13e-05	6.2e-05	CcSEcCtD
Levobupivacaine—Dyspnoea—Doxorubicin—hematologic cancer	2.11e-05	6.16e-05	CcSEcCtD
Levobupivacaine—Feeling abnormal—Epirubicin—hematologic cancer	2.11e-05	6.15e-05	CcSEcCtD
Levobupivacaine—Somnolence—Doxorubicin—hematologic cancer	2.11e-05	6.14e-05	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.1e-05	6.11e-05	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.09e-05	0.000573	CbGpPWpGaD
Levobupivacaine—Dyspepsia—Doxorubicin—hematologic cancer	2.09e-05	6.08e-05	CcSEcCtD
Levobupivacaine—Vomiting—Prednisone—hematologic cancer	2.08e-05	6.07e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism—FTCD—hematologic cancer	2.08e-05	0.000569	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PHYH—hematologic cancer	2.08e-05	0.000569	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GMPS—hematologic cancer	2.08e-05	0.000569	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.06e-05	0.000565	CbGpPWpGaD
Levobupivacaine—Decreased appetite—Doxorubicin—hematologic cancer	2.06e-05	6.01e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.05e-05	0.000563	CbGpPWpGaD
Levobupivacaine—Headache—Prednisone—hematologic cancer	2.05e-05	5.98e-05	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.05e-05	5.97e-05	CcSEcCtD
Levobupivacaine—Urticaria—Epirubicin—hematologic cancer	2.04e-05	5.93e-05	CcSEcCtD
Levobupivacaine—Pain—Doxorubicin—hematologic cancer	2.03e-05	5.91e-05	CcSEcCtD
Levobupivacaine—Constipation—Doxorubicin—hematologic cancer	2.03e-05	5.91e-05	CcSEcCtD
Levobupivacaine—Abdominal pain—Epirubicin—hematologic cancer	2.03e-05	5.9e-05	CcSEcCtD
Levobupivacaine—Body temperature increased—Epirubicin—hematologic cancer	2.03e-05	5.9e-05	CcSEcCtD
Levobupivacaine—Hypersensitivity—Methotrexate—hematologic cancer	2.02e-05	5.88e-05	CcSEcCtD
Levobupivacaine—Asthenia—Methotrexate—hematologic cancer	1.97e-05	5.73e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.96e-05	0.000537	CbGpPWpGaD
Levobupivacaine—Feeling abnormal—Doxorubicin—hematologic cancer	1.95e-05	5.69e-05	CcSEcCtD
Levobupivacaine—Nausea—Prednisone—hematologic cancer	1.95e-05	5.67e-05	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.94e-05	5.65e-05	CcSEcCtD
Levobupivacaine—Pruritus—Methotrexate—hematologic cancer	1.94e-05	5.65e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.94e-05	0.000531	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.92e-05	0.000527	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—HRAS—hematologic cancer	1.92e-05	0.000527	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SMPD3—hematologic cancer	1.9e-05	0.000521	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.89e-05	0.000519	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.89e-05	0.000519	CbGpPWpGaD
Levobupivacaine—Hypersensitivity—Epirubicin—hematologic cancer	1.89e-05	5.5e-05	CcSEcCtD
Levobupivacaine—Urticaria—Doxorubicin—hematologic cancer	1.88e-05	5.49e-05	CcSEcCtD
Levobupivacaine—Body temperature increased—Doxorubicin—hematologic cancer	1.87e-05	5.46e-05	CcSEcCtD
Levobupivacaine—Abdominal pain—Doxorubicin—hematologic cancer	1.87e-05	5.46e-05	CcSEcCtD
Levobupivacaine—Diarrhoea—Methotrexate—hematologic cancer	1.87e-05	5.46e-05	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—HRAS—hematologic cancer	1.85e-05	0.000508	CbGpPWpGaD
Levobupivacaine—Asthenia—Epirubicin—hematologic cancer	1.84e-05	5.36e-05	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—IL6—hematologic cancer	1.84e-05	0.000504	CbGpPWpGaD
Levobupivacaine—Pruritus—Epirubicin—hematologic cancer	1.81e-05	5.28e-05	CcSEcCtD
Levobupivacaine—Dizziness—Methotrexate—hematologic cancer	1.81e-05	5.28e-05	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—IL6—hematologic cancer	1.77e-05	0.000486	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.77e-05	0.000485	CbGpPWpGaD
Levobupivacaine—Diarrhoea—Epirubicin—hematologic cancer	1.75e-05	5.11e-05	CcSEcCtD
Levobupivacaine—Hypersensitivity—Doxorubicin—hematologic cancer	1.75e-05	5.09e-05	CcSEcCtD
Levobupivacaine—Vomiting—Methotrexate—hematologic cancer	1.74e-05	5.07e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.73e-05	0.000473	CbGpPWpGaD
Levobupivacaine—Headache—Methotrexate—hematologic cancer	1.72e-05	5e-05	CcSEcCtD
Levobupivacaine—Asthenia—Doxorubicin—hematologic cancer	1.7e-05	4.96e-05	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—AKT1—hematologic cancer	1.7e-05	0.000465	CbGpPWpGaD
Levobupivacaine—Dizziness—Epirubicin—hematologic cancer	1.7e-05	4.94e-05	CcSEcCtD
Levobupivacaine—Pruritus—Doxorubicin—hematologic cancer	1.68e-05	4.89e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism—B3GAT1—hematologic cancer	1.66e-05	0.000455	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—DCK—hematologic cancer	1.66e-05	0.000455	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ASNS—hematologic cancer	1.66e-05	0.000455	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—AKT1—hematologic cancer	1.64e-05	0.000448	CbGpPWpGaD
Levobupivacaine—Vomiting—Epirubicin—hematologic cancer	1.63e-05	4.75e-05	CcSEcCtD
Levobupivacaine—Nausea—Methotrexate—hematologic cancer	1.63e-05	4.74e-05	CcSEcCtD
Levobupivacaine—Diarrhoea—Doxorubicin—hematologic cancer	1.62e-05	4.73e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.62e-05	0.000445	CbGpPWpGaD
Levobupivacaine—Headache—Epirubicin—hematologic cancer	1.61e-05	4.68e-05	CcSEcCtD
Levobupivacaine—CYP3A4—Metabolism—GMPS—hematologic cancer	1.6e-05	0.000439	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PHYH—hematologic cancer	1.6e-05	0.000439	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—FTCD—hematologic cancer	1.6e-05	0.000439	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HDC—hematologic cancer	1.57e-05	0.000431	CbGpPWpGaD
Levobupivacaine—Dizziness—Doxorubicin—hematologic cancer	1.57e-05	4.57e-05	CcSEcCtD
Levobupivacaine—Nausea—Epirubicin—hematologic cancer	1.52e-05	4.44e-05	CcSEcCtD
Levobupivacaine—Vomiting—Doxorubicin—hematologic cancer	1.51e-05	4.39e-05	CcSEcCtD
Levobupivacaine—Headache—Doxorubicin—hematologic cancer	1.49e-05	4.33e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.47e-05	0.000402	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.47e-05	0.000402	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CDA—hematologic cancer	1.44e-05	0.000394	CbGpPWpGaD
Levobupivacaine—Nausea—Doxorubicin—hematologic cancer	1.41e-05	4.1e-05	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism—PC—hematologic cancer	1.39e-05	0.00038	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GBA—hematologic cancer	1.34e-05	0.000367	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC35B2—hematologic cancer	1.34e-05	0.000367	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.28e-05	0.000351	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—DCK—hematologic cancer	1.28e-05	0.000351	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ASNS—hematologic cancer	1.28e-05	0.000351	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MTAP—hematologic cancer	1.22e-05	0.000335	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HDC—hematologic cancer	1.21e-05	0.000333	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CDA—hematologic cancer	1.11e-05	0.000304	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—FHL2—hematologic cancer	1.09e-05	0.000299	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AGRN—hematologic cancer	1.07e-05	0.000293	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PC—hematologic cancer	1.07e-05	0.000293	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.03e-05	0.000283	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GBA—hematologic cancer	1.03e-05	0.000283	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—IDH2—hematologic cancer	1.01e-05	0.000278	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HMMR—hematologic cancer	1.01e-05	0.000278	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.56e-06	0.000262	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ARNTL—hematologic cancer	9.53e-06	0.000261	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MTAP—hematologic cancer	9.44e-06	0.000259	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ACP5—hematologic cancer	9.27e-06	0.000254	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CA9—hematologic cancer	9.27e-06	0.000254	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NCOR2—hematologic cancer	9.15e-06	0.000251	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—IDH1—hematologic cancer	8.72e-06	0.000239	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCC3—hematologic cancer	8.62e-06	0.000236	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TXN—hematologic cancer	8.62e-06	0.000236	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTO1—hematologic cancer	8.62e-06	0.000236	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SPHK1—hematologic cancer	8.44e-06	0.000231	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—FHL2—hematologic cancer	8.42e-06	0.000231	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AGRN—hematologic cancer	8.25e-06	0.000226	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	8.1e-06	0.000222	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	7.88e-06	0.000216	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CRABP1—hematologic cancer	7.88e-06	0.000216	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—IDH2—hematologic cancer	7.82e-06	0.000214	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HMMR—hematologic cancer	7.82e-06	0.000214	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALOX5—hematologic cancer	7.68e-06	0.000211	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NUP98—hematologic cancer	7.44e-06	0.000204	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ARNTL—hematologic cancer	7.36e-06	0.000202	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ADCY7—hematologic cancer	7.22e-06	0.000198	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NCOA3—hematologic cancer	7.22e-06	0.000198	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NUP214—hematologic cancer	7.17e-06	0.000197	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CA9—hematologic cancer	7.16e-06	0.000196	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ACP5—hematologic cancer	7.16e-06	0.000196	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.1e-06	0.000195	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NCOR2—hematologic cancer	7.06e-06	0.000194	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCG2—hematologic cancer	7.03e-06	0.000193	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MTR—hematologic cancer	7.03e-06	0.000193	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ENO2—hematologic cancer	6.89e-06	0.000189	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—IDH1—hematologic cancer	6.73e-06	0.000184	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTT1—hematologic cancer	6.68e-06	0.000183	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TXN—hematologic cancer	6.65e-06	0.000182	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTO1—hematologic cancer	6.65e-06	0.000182	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCC3—hematologic cancer	6.65e-06	0.000182	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.58e-06	0.00018	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SDC1—hematologic cancer	6.53e-06	0.000179	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SPHK1—hematologic cancer	6.51e-06	0.000178	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	6.25e-06	0.000171	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.24e-06	0.000171	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.16e-06	0.000169	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.08e-06	0.000167	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.08e-06	0.000167	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.93e-06	0.000163	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.89e-06	0.000162	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NUP98—hematologic cancer	5.74e-06	0.000157	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ADCY7—hematologic cancer	5.57e-06	0.000153	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NCOA3—hematologic cancer	5.57e-06	0.000153	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CD44—hematologic cancer	5.55e-06	0.000152	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NQO1—hematologic cancer	5.55e-06	0.000152	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NUP214—hematologic cancer	5.54e-06	0.000152	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.44e-06	0.000149	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.42e-06	0.000149	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MTR—hematologic cancer	5.42e-06	0.000149	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ENO2—hematologic cancer	5.32e-06	0.000146	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYCS—hematologic cancer	5.26e-06	0.000144	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	5.22e-06	0.000143	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.16e-06	0.000141	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SDC1—hematologic cancer	5.04e-06	0.000138	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.7e-06	0.000129	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTP1—hematologic cancer	4.63e-06	0.000127	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.48e-06	0.000123	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCB1—hematologic cancer	4.39e-06	0.00012	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CD44—hematologic cancer	4.29e-06	0.000118	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NQO1—hematologic cancer	4.29e-06	0.000118	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTM1—hematologic cancer	4.26e-06	0.000117	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NCOR1—hematologic cancer	4.26e-06	0.000117	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYCS—hematologic cancer	4.06e-06	0.000111	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.03e-06	0.00011	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MTHFR—hematologic cancer	3.76e-06	0.000103	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.58e-06	9.8e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.38e-06	9.28e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.32e-06	9.09e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.29e-06	9.01e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.29e-06	9.01e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	3.16e-06	8.67e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.93e-06	8.04e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.9e-06	7.96e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.78e-06	7.62e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALB—hematologic cancer	2.74e-06	7.52e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.62e-06	7.19e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.44e-06	6.69e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.42e-06	6.64e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.26e-06	6.2e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.14e-06	5.88e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALB—hematologic cancer	2.12e-06	5.8e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PTEN—hematologic cancer	2.09e-06	5.74e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.03e-06	5.55e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—EP300—hematologic cancer	2e-06	5.47e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.87e-06	5.13e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.62e-06	4.43e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—EP300—hematologic cancer	1.54e-06	4.22e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.48e-06	4.05e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AKT1—hematologic cancer	1.21e-06	3.31e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.14e-06	3.12e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AKT1—hematologic cancer	9.31e-07	2.55e-05	CbGpPWpGaD
